Mounjaro®
Starting from £179.99/mo
Start journey Learn moreUsing semaglutide well isn't simply a matter of injecting once a week and waiting. The best way to use semaglutide involves consistent timing, the right injection technique, and a few habits around food and activity that work with the medicine rather than against it. Semaglutide is a prescription-only medicine; a prescriber assesses whether it is appropriate for you before treatment begins, and their guidance takes priority over any general advice. The facts below reflect what the clinical evidence and NHS guidance on semaglutide consistently point to as the factors that shape how well treatment goes.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The biggest misconception about semaglutide is that injecting it once a week is sufficient on its own. It isn't, and the clinical trials that produced those headline weight-loss figures (around 15% average body weight over 68 weeks in the STEP 1 trial, published in the New England Journal of Medicine) were conducted alongside a reduced-calorie diet and increased physical activity. The medicine reduces appetite and slows how quickly your stomach empties, which makes eating less considerably easier. But it does not automatically steer you toward nutrient-dense foods, protect muscle mass, or keep you hydrated.
What this means in practice: the reduction in appetite that semaglutide produces can make it tempting to eat very little and avoid meals altogether. That tends to backfire. Skipping protein in particular accelerates muscle loss during a calorie deficit, and muscle loss slows your metabolism over time. People who do best on treatment tend to use the reduced hunger as space to eat more carefully, not simply less. That reframe is one of the most useful things a prescriber or dietitian can offer at the start of treatment.
The semaglutide overview page covers how the medicine works in more detail if you want the full mechanism before reading on.
Semaglutide (Wegovy) is injected subcutaneously (into the fat layer just beneath the skin) once a week. The standard sites are the abdomen, thigh or upper arm; rotating between them reduces the chance of skin thickening or irritation at any single spot. The needle should go in at a 90-degree angle to the skin for most people. Pinching the skin first is usually recommended.
Timing consistently on the same day each week is the most practical thing you can do to keep blood levels stable. If you miss a day, the Patient Information Leaflet and your prescriber's advice govern what to do, general rules for missed doses vary by situation and shouldn't be guessed at. What you eat immediately after injecting is less important than what you eat across the week, but many people find that a heavy, fatty meal shortly after injecting worsens nausea in the early weeks.
Your pen arrives refrigerated, tracked by DPD, in plain unbranded packaging. Store it in the fridge at 2–8°C. The exact window for keeping it at room temperature if needed (when travelling, for example) is stated in your Patient Information Leaflet; follow that rather than any figure quoted online. If you want a clear walkthrough of the best way to take semaglutide for weight loss, including how to handle the pen correctly and build a consistent weekly routine, our dedicated guide goes through each step.
Nausea is the most commonly reported side effect in the early weeks of semaglutide treatment. It is usually mild to moderate and tends to settle as the body adjusts, but there are practical ways to reduce it. Eating smaller portions more slowly, avoiding very rich or spicy food around injection day, and staying well hydrated all help. Fizzy drinks can worsen bloating, which already increases when gastric emptying slows. Alcohol tends to amplify nausea too.
Protein is worth paying deliberate attention to. A rough target of 1.2–1.6 g per kilogram of body weight per day is commonly used in clinical contexts during active weight loss to preserve muscle, though your prescriber can advise on what's appropriate for you personally. Fibre from vegetables, pulses and wholegrains supports gut motility, important because constipation is another common side effect. Strength-based activity, even bodyweight exercise, works alongside adequate protein to maintain muscle during a calorie deficit.
The guide to using Wegovy for weight loss covers the lifestyle side of treatment in more detail, including what the trial evidence says about exercise during GLP-1 therapy.
Semaglutide treatment starts at a low dose to let the body adjust gradually. The schedule moves through several steps before reaching the maintenance dose, your prescriber sets that pace, not how hungry or full you happen to feel. Pushing for a faster increase because you feel fine is not clinically appropriate; nor is staying at a lower dose indefinitely because higher doses feel daunting. If you are based in the Chilton area, our Chilton semaglutide service can connect you with a local prescriber who will manage that progression with you directly.
If nausea is severe, persistent vomiting is preventing you from keeping food down, or you experience severe stomach pain that reaches through to your back, these are reasons to contact your prescriber or seek medical help promptly. The MHRA monitors GLP-1 medicines closely, and side effects including serious ones can be reported at the MHRA Yellow Card scheme. For anything that concerns you between reviews, the aftercare team is available seven days a week.
If you are thinking about how to end treatment when the time comes, stopping Wegovy safely is worth reading before making that decision alone. And if you are still in the process of deciding whether semaglutide is the right option for you, speaking to our prescribers is the place to start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.